AKT1 and cancer: For this type of cancer, various studies have shown that HER2 is responsible for increased activation of a signaling pathway called PI3-K/Akt (phosphoinositide-3-kinase/protein kinase B), which is considered to play an essential role in disease progression [6,7,8,9].